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Background: Malaria transmission occurs during the blood feeding of infected anopheline mosquitoes
concomitant with a saliva injection into the vertebrate host. In sub-Saharan Africa, most malaria transmission is due
to Anopheles funestus s.s and to Anopheles gambiae s.l. (mainly Anopheles gambiae s.s. and Anopheles arabiensis).
Several studies have demonstrated that the immune response against salivary antigens could be used to evaluate
individual exposure to mosquito bites. The aim of this study was to assess the use of secreted salivary proteins as
specific biomarkers of exposure to An. gambiae and/or An. funestus bites.
Methods: For this purpose, salivary gland proteins 6 (SG6) and 50nucleotidases (50nuc) from An. gambiae (gSG6 and
g-50nuc) and An. funestus (fSG6 and f-50nuc) were selected and produced in recombinant form. The specificity of
the IgG response against these salivary proteins was tested using an ELISA with sera from individuals living in three
Senegalese villages (NDiop, n = 50; Dielmo, n = 38; and Diama, n = 46) that had been exposed to distinct densities
and proportions of the Anopheles species. Individuals who had not been exposed to these tropical mosquitoes
were used as controls (Marseille, n = 45).
Results: The IgG responses against SG6 recombinant proteins from these two Anopheles species and against
g-50nucleotidase from An. gambiae, were significantly higher in Senegalese individuals compared with controls who
were not exposed to specific Anopheles species. Conversely, an association was observed between the level of An.
funestus exposure and the serological immune response levels against the f-50nucleotidase protein.
Conclusion: This study revealed an Anopheles salivary antigenic protein that could be considered to be a promising
antigenic marker to distinguish malaria vector exposure at the species level. The epidemiological interest of such
species-specific antigenic markers is discussed.
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Malaria remains a major public health burden, affecting
approximately 240 million individuals annually and caus-
ing more than 800,000 deaths, mainly in populations liv-
ing in tropical and sub-tropical countries in sub-Saharan
Africa [1]. To date, the absence of a licensed malaria
vaccine [2-4] and the spread of parasite resistance against
malaria treatment [5] necessitate strengthening the con-
trol of malaria exposure by avoiding host/vector contact.
Thus, several strategies could be used to protect indivi-
duals from mosquito bites, either by using personal anti-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and long-sleeved clothes [6], or by controlling vector
populations at both the adult and larval stages [7,8]. The
effectiveness of these anti-vectorial devices is generally
evaluated with parasitological and entomological methods
[9-11]. Although these methods have demonstrated their
capacity to estimate human exposure to malaria vectors
and Anopheles densities, these tools lack important logis-
tics and present limited efficiency in the context of low-
level exposure to Anopheles bites. In addition, they are not
designed for the assessment of the heterogeneity of mos-
quito exposure at the individual level [9]. Therefore, the
development of new indicators and methods to evaluate
the effectiveness of anti-vectorial strategies at the individ-
ual level is necessary.
Mosquito salivary proteins injected into the host dur-
ing blood feeding play a dual role by counteracting
homeostasis and modulating the vertebrate immune re-
sponse [12]. In addition to their role in the blood meal,
some salivary proteins presenting immunogenic proper-
ties could elicit an antibody response by their host. This
immune response, initially described in allergic indivi-
duals [13], has been proposed as a marker of exposure
to mosquito bites [14,15]. Thus far, several studies have
demonstrated that the level of IgG immune responses
against salivary antigens is associated with the level of
individual exposure to mosquito bites, which may vary
according to seasonal mosquito density [15,16], transient
exposure following travel in malaria-endemic areas [17]
or following the introduction of anti-vectorial measures,
such as the use of insecticide-treated nets [18]. However,
the existence of homologous salivary protein sequences
that are shared among different species from Culicidae
requires the identification of specific antigenic proteins
or peptides prior to developing any anti-saliva based im-
munological tools to assess individual exposure to differ-
ent mosquito vectors [9,19].
Among mosquito salivary proteins, the Anopheles gam-
biae salivary gland protein 6 (gSG6) was proposed as a
potential candidate for the examination of specific malaria
vector exposure markers [20]. This small protein, ex-
pressed specifically in the salivary glands of adult female
mosquitoes, was selected based on its restrictive presence
in species belonging to the subgenus Cellia, including
major Afrotropical malaria vectors (e g, An. gambiae spe-
cies complex, Anopheles funestus) [21], and its immune
recognition by individuals exposed to Anopheles [17]. To
limit production costs, Poinsignon and colleagues de-
signed a gSG6-based peptide sequence (gSG6-P1) accor-
ding to its predicted immunogenic properties [20]. The
gSG6-P1 peptide was repeatedly reported to be a relevant
An. gambiae-specific marker of exposure [20-23]. More-
over, the high level of amino-acid conservation between
gSG6-P1 peptide sequences from An.gambiae and An.funestus indicate the potential of this peptide to be an
indicator of exposure to both of these main vectors of
Plasmodium falciparum in Africa [24]. Similar observa-
tions were obtained using recombinant forms of whole
SG6 orthologs from An. gambiae and An. funestus [25,26],
which could be attributed to the high level of identity
among them (i.e., 80%). More recently, it was reported
that the level of IgG against gSG6 was positively linked to
the risk of malaria pathogen transmission [27]. Thus, SG6
proteins are currently the best and uniquely relevant indi-
cators of exposure to Afrotropical malaria vectors.
However, the identification of salivary antigenic candi-
dates capable of discriminating individual exposure at
the species level could improve the development of this
type of immunological test by determining the anophe-
line fauna biting population. Effectively, together with
An. funestus, mosquitoes from the An. gambiae s.l.
(An. gambiae s.s. and Anopheles arabiensis) are the most
common vectors of human malaria in sub-Saharan
Africa [28]. These highly anthropophilic Anopheles spe-
cies could geographically co-inhabit most sub-Saharan
countries [29]. Malaria parasites can thus be transmitted
by multiple and often sympatric vectors [30-32]. How-
ever, anopheline fauna could be spatially and temporally
influenced by several factors, such as environmental
conditions that could seasonally modify the anopheline
species proportions and densities. During the dry season,
the An. gambiae s.l. density is decreased for the benefit
of An. funestus. The maintenance of malaria transmi-
ssion at several sites could be attributed to the presence
of An. funestus [33]. Thus, in addition to the use of saliv-
ary exposure markers to estimate the individual level of
exposure to Afrotropical malaria vectors, the charac-
terization of new species-specific anopheline salivary
antigenic candidates could be useful for determining the
predominant mosquito populations of a study area. Such
information could be useful for the adaptation of vecto-
rial control measures against specific mosquito popu-
lations or for the estimation of the risk of malaria
transmission or persistence.
Thus, the aim of this study was to assess anopheline sal-
ivary proteins that could be used as species-specific expos-
ure biomarkers to distinguish An. funestus exposure from
An. gambiae s.l. exposure. First, SG6 salivary proteins from
An. gambiae s.s. (gSG6) and An. funestus (fSG6) were
produced in recombinant forms and evaluated on sera
from individuals that were either un-exposed to Anopheles
or exposed predominantly to An. funestus or An. gambiae
s.l., to confirm that these salivary proteins could be used
to detect a predominant exposure to either of these two
mosquito species. In addition, recombinant forms of
50nucleotidase salivary proteins from An. gambiae s.s.
(g-50nuc) and An. funestus (f-50nuc) were tested on the
same sera to assess their potential as species-specific
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against these selected salivary proteins at the genus or spe-
cies levels was analyzed by ELISA using sera from indivi-
duals living in three Senegalese villages (NDiop, n = 50;
Dielmo, n = 38; and Diama, n = 46) exposed to distinct
densities and proportions of the Anopheles species. Indivi-
duals that were not exposed to these tropical mosquitoes
were used as controls (Marseille, n = 45).
Methods
Ethics statement
The protocol (N°2006-A00581-50) was approved by the
Marseille-2 Ethical Committee (France) and by the Senegal
National Ethics Committee (Dakar, Senegal). The written
informed consent of each participant was obtained at the
beginning of the study, after a thorough explanation of its
purpose.
Study sites, sera samples and entomological observations
The study was conducted on two different populations:
un-exposed people and people who were regularly exposed
to An. gambiae s.l. and An. funestus bites. Forty-five serum
samples from French adults living in Marseille (43°170N,
5°220E; mean age ± standard deviation (SD): 40.73 ± 12.02,
sampled in February 2007 [16]), who had never been in
countries endemic for An. gambiae s.l. and An. funestus,
were used as un-exposed negative controls. The exposed
group consisted of 134 individuals living in the Senegalese
villages of Diama (16°130 N, 16°230W; n = 46, mean age ±Table 1 Characteristics of density and exposure to Anopheles
Location Number of
Anopheles caught
Pe
co
Diama 1,492
An. gambiae s.l. 17 1.1
An. gambiae s.s. n.d. n.d
An. arabiensis n.d. n.d
An. funestus 0 0.0
Others Anophelines (86.9% of An. pharoensis) 1475 98
Dielmo 1,473
An. gambiae s.l. 494 33
An. gambiae s.s. 13 0.9
An. arabiensis 481 32
An. funestus 978 66
Others Anophelines 1 0.0
NDiop 597
An. gambiae s.l. 565 94
An. gambiae s.s. 190 32
An. arabiensis 373 63
An. funestus 28 4.7
Others Anophelines 4 0.7
n.d.: not determined, HBR: human biting rate.SD: 17.96 ± 11.58, sampled between March and October
1994), Dielmo (13°450N, 16°250W; n = 38, 28.38 ± 21.26,
sampled in March 1995) and Ndiop (13°140N, 16°230W;
n = 50, 25.87 ± 18.34, sampled between March and
December 1995). These populations were exposed to high
(Dielmo, approximately a 30.6 human biting rate (HBR),
moderate (Ndiop, approximately a 3.9 HBR) and low
(Diama, <1 HBR) Anopheles bite levels. Individuals living
in Dielmo and Ndiop were predominantly exposed to
An. funestus (approximately 66%) and An. gambiae s.l. (ap-
proximately 95%), respectively. Individuals living in Diama
were predominantly exposed to other anopheline mosquito
species (Anopheles pharoensis, approximately 87%). Details
regarding the entomological data are presented in Table 1
and show for each site the amount and the proportion of
each anopheline species collected from the three months
preceding blood sampling until the end of the blood sam-
pling period. Concerning entomological measures, adult
mosquitoes were collected monthly using human bait
catches and the HBR, which is the number of mosquito
bites per person per night, was calculated as the number of
mosquitoes captured during the month divided by the
number of person-nights. Additional data on the study site,
including entomological and parasitological factors, have
been previously reported [34-40].
Protein expression and purification
The coding sequences for the anopheline proteins gSG6
(gi|13537666), g-50nucleotidase (gi|4582528), fSG6 (gi|bites in each site according to entomological data
rcentage
mposition
HBR
(An./person/night)
Collection
period
References
<1 January '94 –
December '94
[37, 38, 39]
%
.
.
%
.9%
30.6 January '95 to
march '95
[34]
.5% 10.3
% 0.3
.6% 10.0
.4% 20.3
% 0.0
3.9 January '95 –
December '95
[35, 36]
.6% 3.7
% 1.3
% 2.5
% 0.2
% 0.0
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retrieved from the National Center for Biotechnology
Information (NCBI) database. The cDNAs of selected
proteins were synthesized with a C-terminal His-tag and
cloned into the baculovirus expression vector pFast Bac1
(Invitrogen, Cergy Pontoise, France) by Genecust (Gencust,
Dudelange, Luxembourg). The fidelity of the cloned
sequences was verified by DNA sequencing, using an ABI
Prism 3100 analyzer (Applied Biosystems). Recombinant
bacmid DNA was generated in the DH10Bac Escherichia
coli strain (Invitrogen), using the Bac-to-Bac system and
protocol (Invitrogen). Spodoptera frugiperda (Sf9) cells
were transfected with the recombinant bacmid DNA using
the Lipofectin transfection reagent (Invitrogen), according
to the manufacturer’s instructions. The structures of all the
inserts were sequenced for authentic cloning (ABI Prism
3100 analyzer, Applied Biosystems). Confirmed clones were
amplified in Spodoptera frugiperda (Sf9) cells in serum-free
medium (Sf-900 II SFM, Gibco, Carlsbad, CA) to produce
working viral stocks, which were titrated by a plaque assay
and used for subsequent expression studies. For protein
production, Sf9 cells were cultured at 28°C in 800 ml of
suspension culture (1,3×106 Sf9 cells/ml), infected with a
multiplicity of infection of 5 and harvested after three days
by centrifugation at 500 × g for 15 min at 4°C, washing in
PBS and repeating centrifugation. All pellets were stored at
−80°C until use. The cell pellet was resuspended in lysis
buffer (50 mM Tris, pH 7.9, 300 mM NaCl, 20 mM imi-
dazole, with proteolysis inhibitor P8849 (Sigma), and
disrupted using an Emulsiflex C3 cell disruptor (Avestin,
Mannheim, Germany). The cell lysate was clarified by
centrifugation at 40,000 rpm for 45 min at 4°C (45 Tirotor,
Beckman Coulter). The recombinant proteins were puri-
fied using HisTrap HP columns (AKTA purifier 10GEH,
GE Healthcare, France). The fractions containing the His-
tagged recombinant proteins were selected by SDS-PAGE
and pooled. To eliminate contaminant proteins, pooled
fractions of each recombinant protein were then purified
by gel filtration (superdex 75 26/60 column, GE Health-
care). The fractions containing recombinant proteins were
identified by SDS-PAGE, pooled and dialyzed against a 40
mM Tris–HCl buffer (pH 7.5). The protein concentration
was measured using a Lowry DC Protein assay (Bio-Rad,
Hercules, CA, USA). The purity of purified proteins was
determined by SDS-PAGE, and the identity was confirmed
by mass spectrometry (MS).
SDS-PAGE
Five microgram of each purified recombinant protein
were reduced in a Tris buffer containing dithiothreitol
(1% w/v, Sigma), boiled for 5 min, and loaded per well
onto a 15% polyacrylamide gel before to be separated
using a Mini PROTEAN II (BioRad, Hercules, CA,
USA). After electrophoresis, gels were stained withCoomassie brilliant blue R-250 (Imperial™ Protein Stain,
Thermo Scientific, Rockford, IL, USA) and scanned with
a high-resolution densitometer scanner (Image Scanner
3, GE Healthcare) and densitometry profiles were ana-
lysed using the ImageQuant™ TL software (GE Health-
care). Protein bands from gels were excised for further
identification by mass spectrometry. Molecular weights
were estimated by comparison with standard molecular
weight marker (Biorad).
In-gel digestion and mass spectrometry analysis
Excised bands were digested overnight at 37°C with
sequencing-grade trypsin (12.5 μg/mL; Promega Madison,
WI, USA) in 50 mM NH4HCO3 (Sigma). The resulting
peptides were extracted with 25 mM NH4HCO3 for
15 min, dehydrated with acetonitrile (ACN) (Sigma), incu-
bated with 5% acid formic (Sigma) for 15 min under agita-
tion, then dehydrated with ACN, and finally completely
dried using a SpeedVac. The samples were then analysed
on a NanoLC-LTQ-OrbitrapVelos-ETD (Thermo Scien-
tific, Bremen, Germany) for identification.
Enzyme-Linked ImmunoSorbent Assays (ELISA)
ELISA was performed according to standard procedures.
Microtiter 96-well plates (Nunc Maxisorp Immunoplates,
Denmark) were coated for three hours at 37°C with 10 μg/
ml (50 μl/well) of either gSG6, g-50nucleotidase, fSG6 and
f-50nucleotidase purified recombinant anopheline proteins
in 0.1M bicarbonate coating buffer (pH 9.6) (Sigma).
Three washes were done with 200 μL of PBS (pH 7.4,
Sigma, USA) plus 0.05% Tween-20 (Sigma) between each
incubation. Plates were blocked overnight at 4°C with 200
μL of blocking buffer consisting of PBS 0.05% Tween and
5% skimmed milk (Beckton, Dickinson Bioscience, USA).
Serum diluted 1:50 in blocking buffer was added (50 μl/
well) and incubated at 37°C for 1 h. Fifty microliters of
horseradish peroxidase (HRP)-conjugated rabbit anti-
human IgG (1:10,000, Invitrogen, Rockville, USA) diluted
in the blocking buffer were incubated for 1 h at 37°C. En-
zyme activity was detected by incubation with 50 μl of tet-
ramethylbenzidine substrate (KPL, USA) for 10 min at
room temperature in the dark. The reaction was stopped
using 50 μl of 1 M H2SO4. The optical density (OD) at
450 nm was determined with a microplate reader (Versa
MaxW Turnable Multiplate Reader, Molecular Devices,
UK). Each serum was tested in duplicate against the differ-
ent recombinant antigenic proteins and also without anti-
gen (coating buffer only). In order to improve result
consistencies, sera from different study sites have been
randomly loaded on each plate and each individual serum
were tested on the same plate against the four recombin-
ant proteins. A pool of eight sera from individuals living
in Dielmo and Ndiop sites presenting high level of anti-
body responses against the four anopheline recombinant
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tests), were used as a positive control on all plates coated.
Only plates presenting inter-assay variations in absorbance
values of positive controls lower than 20% were included
in the analysis. The levels of IgG antibodies were expressed
as adjusted OD (aOD), which was calculated for each
serum sample duplicate as the mean OD value of antigenic
proteins-coated wells minus the mean OD value of the
background control wells (i.e., coating buffer without anti-
genic proteins). Sera whose duplicates showed a coefficient
of variation (CV) ≥20% were not included in the analysis.
The mean aOD of unexposed individuals plus three stand-
ard deviation (SD) was used as cut-off value for seroposi-
tivity. Seroprevalence was defined as the pourcentage of
seropositive individuals in each group.
Protein sequence analysis
Culicidae protein sequences that were related to the
50nucleotidases from both An. funestus (gi|114864746)
and An. gambiae (gi|4582528) were retrieved from the
National Center for Biotechnology Information (NCBI)
using the BLASTp program. The hit sequences exhibit-
ing a significant alignment (E-value<1.10-4) and a hit
sequence with coverage ≥70% and identity ≥ 50% were
selected for further protein sequence comparisons. Mul-
tiple sequence alignment was performed with the Clustal
W 1.7 multiple sequence alignment program [41], which
is included in the Molecular Evolutionary genetic Ana-
lysis 5 (MEGA 5) programs package [42].
Statistical analysis
After verifying that values in each group did not assume a
Gaussian distribution, the Kruskal-Wallis test was used
for multiple group comparisons and the Friedman test
was used to compare observations repeated on the same
subjects in each study site. Two independent groups were
compared by the Mann–Whitney U test. The Wilcoxon
signed-rank test was used for comparison of two paired
groups. Frequencies were compared by the Pearson’s Chi-
squared test and Spearman’s rank correlation coefficient
was computed when appropriate. All differences were
considered significant at p <0.05 and statistical analysis
and figures were performed using the computing environ-
ment R (R Development Core Team, 2012).
Results and discussion
Degree of conservation of salivary proteins
Members of the 50nucleotidase/Apyrase family have
been ubiquitously found in the saliva of hematophagous
arthropods [19]. These enzymes are known to facilitate
the acquisition of blood meals by removing and degrad-
ing pharmacologically active nucleotides (i.e., ATP/ADP)
that are important for platelet aggregation at the site of
the injury [43]. Three members of the 50nucleotidasegene family were described at the transcript level in An.
gambiae salivary glands [44]. Among them, the putative
50nucleotidase (gi|4582528) from An. gambiae (g-50nuc)
was highly expressed compared to the other two
50nucleotidase family members. The identification of the
putative 50nucleotidase at the protein level in An. gam-
biae saliva (64 kDa) confirmed that this salivary protein
could be injected into the host during blood feeding
[45]. Moreover, the induction of host antibody responses
against members of the 50nucleotidase/Apyrase protein
family has previously been reported [46-48]. Collectively,
these data suggested that 50nucleotidase proteins could
be used as potential immunological exposure markers to
mosquito bites. To determine whether members from
this protein family could be selected as antigenic candi-
dates for the evaluation of exposure to mosquito bites at
the species level, the degree of protein sequence diversity
in the 50nucleotidase/Apyrase protein family among spe-
cies from Culicidae was evaluated.
Among 50nucleotidase anopheline proteins, the 50nuc-
leotidase from An. funestus (f-50nuc; gi|114864746) was
selected based on its protein sequence peculiarities. In-
deed, alignment of this sequence with the An. gambiae
putative 50nucleotidase (g-50nuc; gi|4582528) indicated
that the protein from An. funestus lacks a large part of
the amino-terminal domain (Additional file 1). The mo-
lecular weights and sizes (a.a. length) of f-50nuc protein
sequences (17 kDa, 139 a.a.) differ from those of g-50nuc
(64 kDa, 570 a.a.), which leads to a low coverage se-
quence (31%) and a moderate identity (<75%). When
blasting the f-50nuc protein sequence (gi|114864746)
against the Culicidae protein database on NCBInr (NIH,
Bethesda), 13 protein hits containing homologous se-
quences could be retrieved (E-value<1.10-4, coverage
≥70% and identity ≥ 50%). An alignment of the f-50nuc
protein sequence (gi|114864746) with the members of
the 50nucleotidase/Apyrase family from other Culicidae
indicated that orthologous protein sequences from the
Anopheles and Aedes genera presented amino-acid se-
quence similarities (Figure 1). Among these homologous
proteins, two 50nucleotidase/Apyrase proteins from An.
gambiae (gi|4582528 and gi|58377530) and one from
Anopheles stephensi (gi|27372911) presented amino-acid
identities between 72-75%, and the identity levels drop
to less than 56% for all of the other selected proteins,
suggesting an important diversity in this sequence among
Culicidae. Interestingly, among all the sequences re-
trieved, only two members of the 50nucleotidase/Apyrase
family (gi|208657657, gi|208657659) from the Anopheles
darlingi species were also truncated at their amino-
terminal end, but these proteins presented moderate iden-
tities (<55%) with the 50nucleotidase from An. funestus.
Thus, taken together, the f-50nuc protein peculiarities (i.e.,
a moderate level of sequence conservation within the
Figure 1 Alignment of Culicidae protein members from the 50 nucleotidase/Apyrase family. Using the BLASTp program, 13 Culicidae
protein sequences related to 50nucleotidase (gi|114864746) from An. funestus were selected (E-value<1.10-4, coverage ≥70% and identity ≥ 50%).
An alignment of Culicidae 50nucleotidase/apyrase proteins to 50nucleotidase from An. funestus (f50nuc, gi|114864746) was performed with
ClustalW. Only the parts of the protein sequence aligned with the f50nuc protein sequence are presented. Mosquito species, protein name,
accession numbers and amino-acid positions are indicated, and conserved amino acids are shaded. The percentages of identical amino acid
residues and sequence recovering compared with f50nuc (gi|114864746) are listed for each of the selected proteins.
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high abundance of these family proteins in the anopheline
saliva and their involvement in eliciting host antibody
responses) have highlighted our interest in assessing this
protein as a potential marker candidate to distinguish ex-
posure to An. funestus from exposure to An. gambiae s.l..
Concerning g50nuc (gi|4582528), a sequence alignment
showed that members of the 50nucleotidase/Apyrase
family share only a moderate level of conservation of the
protein sequences (<66% identical amino acids residues),
with the exception of a paralogous protein from An.
gambiae (gi|58377530) and a salivary apyrase from An.
stephensi (gi|27372911) that possess 99% and 80% iden-
tical amino acid residues, respectively (Additional file 2).
Due to their determinant role in blood feeding, these
enzymes could be submitted to environmental pressures
that lead to heterogeneous and independent sequence
evolution.
SG6 proteins (gSG6, gi|13537666 and fSG6, gi|
114864550) were previously described to be restrictively
present in the Cellia subgenus and are well conserved
within this anopheline subgenus (Additional file 3) [21].
SG6 recombinant proteins were thus used as a reference
immunological tool to evaluate the level of exposure to
anopheline mosquitoes.
Production of recombinant SG6 and 50nucleotidase
salivary orthologs from An. gambiae and An. funestus
A poly-histidine tag was added to the C-terminus of
each recombinant protein to ensure the purification of
whole recombinant proteins. gSG6 and g-50nuc salivary
proteins from An. gambiae, and fSG6 and f-50nucsalivary proteins from An. funestus were produced in Sf9
cells using a baculovirus expression system and were
purified by affinity chromatography (HisTrap HP) and a
gel filtration column. The fractions corresponding to re-
combinant proteins were separated by SDS-PAGE, and a
representative purified fraction for each protein is pre-
sented in Figure 2. As expected, protein bands with
apparent molecular weights corresponding to gSG6 and
fSG6 protein fractions were detected at approximately
13 kDa, and fractions corresponding to g-50nuc and
f-50nuc were detected at approximately 65 kDa and 17
kDa, respectively. Proteins bands of interest were excised
from the gel and submitted to mass spectrometry ana-
lysis, which confirmed that the detected bands corre-
sponded to the expected recombinant proteins (Table 2).
Protein profiles were analyzed using ImageQuant™ TL
software to determine the relative abundance of each
purified recombinant protein as previously described
[49,50]. The purity of the different recombinant proteins
was greater than 90%, and the protein fractions were
considered sufficiently pure for ELISA experiments.
IgG response against gSG6 and fSG6 proteins according
to anopheline populations and densities
Recently, Rizzo and collaborators evaluated the IgG res-
ponses in individuals living in a malaria hyperendemic area
of Burkina Faso against recombinant gSG6 and fSG6 pro-
teins from An. gambiae and An. funestus, respectively [26].
These individuals, exposed predominantly to An. gambiae
s.l. bites, produced a comparable immune response against
both SG6 salivary proteins, indicating a wide cross-
reactivity between these anopheline orthologous proteins.
Figure 2 The assessment of the expression and purification of
anophelines salivary proteins. Recombinant ortholog forms of
SG6 and 50nucleotidases from An. gambiae and An. funestus
expressed in Spodoptera frugiperda (Sf9) cells and purified by
affinity and gel filtration chromatography were separated on a 15%
SDS-PAGE and post-stained with Imperial™ Protein Stain (Thermo
Scientific). Five micrograms of each collected fraction were loaded
per well. The protein name and the Anopheles species
corresponding to each well are indicated at the top of the gel. The
Roman numeral numbers on the right side of the gel correspond to
the band numbers excised for identification by mass spectrometry.
Band identity is listed in Table 2. Standard molecular weights are
indicated on the left side. MW: molecular weight. kDa: kilodalton.
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members of the An. gambiae species complex (greater than
99%) and members of the Cellia subgenus, such as An.
funestus (with an identity of approximately 80%), supports
this idea of shared-antigens [21,25,26]. Based on these
results, the gSG6 salivary protein was considered to be a
valuable serological marker of exposure to Afrotropical
malaria vectors.However, Rizzo and collaborators did not evaluate the
IgG responses against these two orthologous SG6 proteins
in individuals exposed predominantly to An. funestus
mosquito bites. To determine whether variations in the
anopheline populations and densities could influence the
IgG responses against recombinant orthologs of SG6
proteins from An. gambiae and An. funestus, the IgG
responses against recombinant gSG6 and fSG6 proteins
were assessed in our study in 134 individuals living in
three Senegalese villages, Diama (n = 46), Ndiop (n = 50)
and Dielmo (n = 38) which are considered to be weakly
(human biting rate (HBR) < 1) [37-39], moderately (HBR =
3.9) [35,36] and highly (HBR = 30.6) exposed to Anopheles
bites [34], respectively. These individuals were exposed to
distinct anopheline populations, with a predominance of
An. pharoensis (approximately 87%) and An. gambiae s.l.
mosquitoes (greater than 94%) in Diama and NDiop,
respectively, and a majority of An. funestus mosquitoes
(66.4%) in Dielmo (Table 1). Sera from European indivi-
duals (n = 45) living in Marseille, collected in February
2007 and never exposed to these tropical malaria vectors,
were used as un-exposed controls. The IgG response
against the gSG6 and fSG6 proteins was assessed by
ELISA.
For gSG6 protein, the IgG responses were significantly
different among the four groups (Kruskal-Wallis test,
p<0.0001, Figure 3A). When comparisons were performed
between two sites, the anti-gSG6 IgG responses were sig-
nificantly higher in exposed individuals from each village
(i.e., the means of aODs with a 95% confident interval
(95%CI) were +0.50 [0.39 to 0.60], +0.65 [0.53 to 0.76] and
+0.58 [0.49 to 0.66] for Diama, Dielmo and NDiop, re-
spectively) compared with un-exposed control individuals
(+0.16 [0.12 to 0.20]; Mann–Whitney U test, p<0.0001).
Conversely, despite distinct exposure levels to Anopheles
bites in these three Senegalese villages, significant differ-
ences were detected only between Diama and Dielmo
(Mann–Whitney U test, p=0.0174). Although the highest
exposure to Anopheles bites was in Dielmo, followed by
NDiop and finally Diama; the seroprevalence (a seroposi-
tivity cut-off was set as the mean aOD of un-exposed con-
trols + 3 SDs: 0.164 + (3 x 0.130) = 0.554), with values of
55%, 52% and 37% in Dielmo, NDiop and Diama, respec-
tively, was not found to be significantly different among the
three villages (Pearson’s Chi-squared test, ns, Figure 3C).
These data support the hypothesis that gSG6 appears to be
a valuable marker for distinguishing individuals who are
un-exposed to anopheline bites from individuals who have
been exposed to anopheline bites, and that this candidate is
also well-adapted for the detection low levels of exposure
to Anopheles bites [20,23]. Although the anti-gSG6 IgG
response could discriminate exposed individuals from
“low” to “high” Anopheles bite densities, such as in Diama
and Dielmo, it seems to be less capable of distinguishing
Table 2 Identification of recombinant salivary proteins by mass spectrometry
Band numbera Accession number
(NCBi)
Protein Name Theoretical MW
(kDa)
Number of MS/MS
peptide sequences
Sequence
coverage (%)
Mascot score
I gi|13537666 gSG6 protein
[An. gambiae]
13.10 9 56.5 1929
II gi|114864550 gSG6 salivary peptide
[An. funestus]
13.06 4 25.4 205
III gi|4582528 putative 50-nucleotidase
[An. gambiae]
63.46 29 48.9 3703
IV gi|114864746 50 nucleotidase
[An. funestus]
16.10 6 49.6 819
a The band number corresponds to the same Roman numeral numbers as indicated in Figure 2.
The identities of the bands, their NCBi accession numbers, the theoretical molecular weight values, as well as the number of peptide sequences identified, the
corresponding percentage sequence coverage and the Mascot score are listed for MS/MS analysis (Individual ions scores > 16 indicate identity or extensive
homology and were considered to be significant (p<0.05).
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high and low exposure sites. The individual heterogeneity
of the IgG responses against gSG6 in each site could
explain this powerless discrimination. This phenomenon
could be attributed to the heterogeneity of AnophelesFigure 3 The IgG response and prevalence to gSG6 and fSG6 accordi
(i.e., proportion of mosquito species). Box plots of aOD values from un-
Ndiop, n = 50) individuals to gSG6 (A) and fSG6 (B) proteins. Antibody resp
recombinant salivary proteins minus the mean OD value of wells with coat
percentile. The whiskers indicate the 90th and 10th percentiles and the do
Mann–Whitney U test (*, p <0.05; **, p <0.01; ***, p <0.001). The seroprevale
value for seropositivity (the mean aOD ± 3 standard deviations) was define
sera from individuals living in Marseille that were not previously exposed to
above the cut-off level for seropositivity were classified as responders. The
Pearson’s Chi-squared test (*, p <0.05; **, p <0.01; ***, p <0.001).exposures according to distinct human behaviors or at-
tractive differences, as recently described [51,52]. To better
appreciate the variations of anti-gSG6 IgG levels, according
to Anopheles densities, a kinetic analysis of the IgG re-
sponse may be more appropriate and necessary.ng to the level of mosquito bites and Anopheles populations
exposed (n = 45) and exposed (Diama, n = 46; Dielmo, n = 38 and
onses are represented by aOD: the mean OD value of wells with
ing buffer. The box plots display the median aOD value, 25th and 75th
ts indicate the outliers. The P value was determined according to a
nce to gSG6 (C) and fSG6 (D) proteins in the four sites. The cut-off
d at 0.55 for gSG6 and 0.59 for fSG6, based on the IgG reactivity of
An. gambiae s.l. and An. funestus. Individuals showing aOD values
whiskers denote the 95% CI. The P values were determined by
Figure 4 Correlation of IgG responses between SG6 ortholog
recombinant proteins from two distinct Anopheles species. A
scatter plot analysis of IgG response to gSG6 is presented, and the
aOD values among the 134 exposed individual are reported. For
gSG6 and fSG6 measurements, the best-fit is shown as a black line
(slope 0.5923±0.0527), with a Spearman’s rank correlation coefficient
(rho) of r = 0.6208, p <0.0001.
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http://www.malariajournal.com/content/11/1/439For the fSG6 protein, significantly different IgG res-
ponses were found among the four groups (Kruskal-Wallis
test, p<0.0001, Figure 3B). These significant differences
were attributed to higher IgG responses from exposed indi-
viduals living in Dielmo (i.e., a mean aOD [95%CI] of +
0.38 [0.29 to 0.48], Mann–Whitney U test, p<0.0001),
NDiop (i.e., + 0.35 [0.26 to 0.44], Mann–Whitney U test,
p<0.0004) and Diama (i.e., + 0.27 [0.19 to 0.34], Mann–
Whitney U test, p=0.0337) compared with un-exposed
control individuals (i.e., + 0.15 [0.10 to 0.19]). As observed
for gSG6, a comparison of the IgG responses between two
Senegalese villages, indicated a significant difference only
between Diama and Dielmo (Mann–Whitney U test,
p=0.0194). The seroprevalence from Diama (17%), Dielmo
(11%) and NDiop (22%) (the seropositivity cut-off was set
as the mean aOD of un-exposed controls + 3 SDs: 0.148 +
(3 × 0.146) = 0.586) was not found to be significantly dif-
ferent among the three villages (Pearson’s Chi-squared test,
p>0.05, Figure 3D). As observed for gSG6, the anti-fSG6
IgG responses increased significantly in populations ex-
posed to Anopheles bites, even in areas of low exposure;
however, this method seems to be insufficiently sensitive to
discern different gradients of Anopheles densities, and the
immune response appears not to be perturbed by the
anopheline fauna variations.Comparison of the IgG response between SG6 orthologs
To estimate the cross-reactivity level of the IgG responses
from exposed individuals of the three Senegalese villages
(n = 134) against SG6 orthologs, a Spearman’s rank correl-
ation coefficient (rho) test was used, and the corresponding
p-values were determined (Figure 4). A significant positive
coefficient correlation (r = 0.6208, p < 0.0001) was
observed between the IgG responses against g-SG6 and f-
SG6 among the exposed individuals. Despite the variations
of Anopheles species proportion among the three villages,
the large majority of individuals were “equivalently” distrib-
uted around the best-fit line. Thus, these observations
strongly support a wide cross-reactivity to the gSG6 and
fSG6 salivary antigens, which is in agreement with a previ-
ous study [26]. In agreement with Rizzo et al., the slope
(0.5923±0.0527) was greater than 0.45, and the best-fit line
runs below the diagonal [26]. This phenomenon resulted
of in a higher IgG response level against gSG6 compared
with fSG6 in the three villages, independent of the Anoph-
eles population proportion. Interestingly, the IgG response
against the fSG6 protein was significantly lower than that
against gSG6, even in areas where individuals are predom-
inantly exposed to An. funestus (Wilcoxon signed-rank
test, p<0.0001, Additional file 4). These results suggest that,
despite high sequence conservation among these ortholo-
gous SG6 proteins, fSG6 appears to be less antigenic than
gSG6. The presence of few species-specific epitopes in eachSG6 protein could explain these differences in IgG
responses [26].
Collectively, these data uphold that SG6 proteins could
be specific markers of exposure to the Anopheles Cellia-
subgenus, and the use of these two proteins could im-
prove the determination of the individual exposure level
to these malaria vectors [26].IgG response against g-50nucleotidase and f-
50nucleotidase proteins according to anopheline
populations and density
The presence of numerous Anopheles species exhibiting
differences in their biology and behavior and variations
in mosquito species proportion and density throughout
the seasons could have major implications for vector
control programs [53,54]. Moreover, the geo-repartition
and the density of the Anopheles species could vary from
area to area in relatively close sites [55], which can in-
crease the complexity of defining the precise regional
malaria vectors responsible for malaria transmission.
Thus, the achievement of species-specific individual ex-
posure markers from major Afrotropical malaria vectors
appears essential to evaluating the appropriateness of
vector control measures and to identifying the Anopheles
species considered to be the main malaria vector in any
area at any given time point.
In addition to the SG6 Anopheline proteins, this study
aimed to evaluate f-50nuc as a possible An. funestus
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the use of anti-f-50nuc IgG responses as a tool to distin-
guish An. funestus exposure from An. gambiae s.l. expos-
ure, the immune responses from individuals of the same
Senegalese villages were evaluated by an ELISA against
50nucleotidase ortholog proteins from these two mosquito
species.
For the g-50nuc protein, the IgG responses were sig-
nificantly different among the four groups (Kruskal-
Wallis test, p<0.0001, Figure 5A). When comparisons
were performed between two sites, the anti-g-50nuc IgG
responses were significantly higher in exposed indivi-
duals from each village (i.e., the mean aODs [95%CI]
were +0.50 [0.40 to 0.61], +0.51 [0.39 to 0.63] and +0.65
[0.52 to 0.77] for Diama, Dielmo and NDiop, respect-
ively) compared with un-exposed control individuals (i.
e., +0.16 [0.12 to 0.21]; Mann–Whitney U test,
p<0.0001). Conversely, no significant differences in theFigure 5 The IgG response and prevalence to g-50nuc and f-50nuc acc
(i.e., proportion of mosquito species). Box plots of aOD values from une
Ndiop, n = 50) individuals to g-50nuc (A) and f-50nuc (B) proteins. Antibody
recombinant salivary proteins minus the mean OD value of wells with coat
percentile. The whiskers indicate the 90th and 10th percentiles and the do
Mann–Whitney U test (*, p <0.05; **, p <0.01; ***, p <0.001). The seroprevale
off value for seropositivity (the mean aOD ± 3 standard deviations) was de
of sera from individuals living in Marseille that were not previously exposed
above the cut-off level for seropositivity were classified as responders. The
Pearson’s Chi-squared test (*, p <0.05; **, p <0.01; ***, p <0.001).anti-g-50nuc IgG responses was found, regardless of
which two groups from these three Senegalese villages
were being compared (Mann–Whitney U test, ns). Al-
though a higher seroprevalence (the seropositivity cut-
off was set as the mean aOD of un-exposed controls + 3
SDs: 0.163 + (3 x 0.147) = 0.604) was detected among
individuals living in the NDiop area (40%), where An.
gambiae s.l. is largely predominant, compared with
Diama (28%) and Dielmo (29%), no significant differ-
ences were found among the three villages (Pearson’s
Chi-squared test, ns, Figure 5C). These data suggest that
the anti-g-50nuc IgG responses could distinguish indivi-
duals un-exposed to Anopheles from individuals exposed
to Anopheles, independent of the level of exposure or
the anopheline fauna.
For the f-50nuc protein, the IgG responses were signifi-
cantly different among the four groups (Kruskal-Wallis
test, p<0.0001, Figure 5B). In particular, the anti-f-50nucording to the level of mosquito bites and Anopheles populations
xposed (n = 45) and exposed (Diama, n = 46; Dielmo, n = 38 and
responses are represented by aOD: the mean OD value of wells with
ing buffer. The box plots display the median aOD value, 25th and 75th
ts indicate the outliers. The P value was determined according to a
nce to g-50nuc (C) and f-50nuc (D) proteins in the four sites. The cut-
fined at 0.60 for g-50nuc and 0.85 f-50nuc, based on the IgG reactivity
to An. gambiae and An. funestus. Individuals showing aOD values
whiskers denote the 95% CI. The P values were determined by
Figure 6 Correlation of IgG responses between 50nucleotidase
ortholog recombinant proteins from two distinct Anopheles
species. A scatter plot analysis of IgG response to f-50nuc is
presented, and the aOD values among the 134 exposed individual
are reported. For g-50nuc and f-50nuc measurements, the best-fit is
shown as a black line (slope 0.1245±0.1036), with a Spearman’s rank
correlation coefficient (rho) of r = 0.1635, p>0.05 (p=0.0591).
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duals living in Dielmo (i.e., + 0.80 [0.65 to 0.96]) and
NDiop (i.e., + 0.63 [0.50 to 0.76]), compared with un-
exposed control individuals (Mann–Whitney U test,
p<0.0001 for these two comparisons) or with individuals
living in Diama (Mann–Whitney U test, p<0.0001 com-
pared with Dielmo and p<0.002 compared with NDiop).
No significant difference was noted between individuals
living in Diama (i.e., a mean aOD [95%CI] of + 0.34 [0.22
to 0.46]) and un-exposed control individuals (i.e., + 0.22
[0.16 to 0.28]; Mann–Whitney U test, ns). The seropreva-
lence (the seropositivity cut-off was set as the mean aOD
of un-exposed controls + 3 SDs: 0.219 + (3 x 0.210) =
0.849) was found to be significantly different among indi-
viduals living in Dielmo (47%) and those living in Diama
(17%) (Pearson’s Chi-squared test, p<0.007, Figure 5D),
corresponding to areas where An. funestus is predomin-
antly present and absent, respectively. The seroprevalence
of individuals living in NDiop (26%) was not significantly
different when compared with the two other Senegalese
villages (Pearson’s Chi-squared test, ns).
The absence of a significant anti-f-50nuc IgG response
among un-exposed individuals and among individuals
living in Diama that were not exposed to An. funestus
bites, in addition to the detection of highly significant
differences in the anti-f-50nuc IgG responses between
individuals not exposed to An. funestus bites and indivi-
duals living in Dielmo or NDiop, suggests that exposure
to An. funestus bites seems to be required to elicit an
antibody response against the f-50nuc protein. Indeed,
the higher IgG response against f-50nuc that was
detected at a site where An. funestus is predominant is a
supplementary argument supporting the idea that this
salivary protein could reflect a species-specific exposure.
Nevertheless, the data could not exclude the possibility
that the anti-f-50nuc IgG responses could correspond to
the level of Anopheles bites. Indeed, the anopheline spe-
cimens collected in these three villages suggested a de-
creasing mosquito density gradient from Dielmo to
Diama, with an intermediate exposure level in NDiop,
which corresponds to the anti-f-50nuc IgG pattern
observed among these three areas. Comparisons of the
anti-f-50nuc IgG responses from individuals exposed
uniquely to An. funestus or to An. gambiae s.l. at equiva-
lent densities could dispel this ambiguity. Nevertheless,
paired comparisons of the IgG responses against 50nuc
orthologous proteins indicated a significant decrease and
increase for individuals living in Diama (Wilcoxon
signed-rank test, p=0.023) and Dielmo (Wilcoxon
signed-rank test, p=0.004), respectively (Additional file
4).These data suggest that the recognition of these saliv-
ary proteins by the immune system was not equivalent
and that specific antigenic epitopes may be associated
with each protein.Comparison of the IgG response between 50nucleotidase
orthologs
To assess the cross-reactivity level of the IgG response
of exposed individuals from the three Senegalese villages
(n = 134) against 50nuc orthologs, a Spearman’s rank
correlation coefficient (rho) test was used, and the corre-
sponding p-values were determined. In contrast to the
SG6 orthologs, no significant correlation was observed
between the IgG responses from exposed individuals
against g-50nuc and f-50nuc recombinant proteins (r =
0.1635, p=0.0591). A high dispersion of the dots was vis-
ible on the scatter plot (Figure 6), underlining the fact
that some individuals presented a larger response to ei-
ther g-50nuc or to f-50nuc proteins. Thus, the antibody
response against these 50nuc ortholog proteins indicated
a low cross-reactivity, suggesting that, despite a partial
conservation of the carboxy-terminal end of these pro-
teins (74% identical), the two proteins may be harboring
“species”-specific epitopes. In addition, the large amino-
terminal segment of g-50nuc (i.e., from amino acid 1 to
434) could possibly possess antigenic sequences that are
absent in f-50nuc and could explain the differences in
serological recognition. Moreover, the g-50nuc amino-
terminal sequence possesses several cysteines (n = 7)
that may be involved in protein folding, which could
change the epitope conformation or mask some epitopes
in the carboxy-terminal (which has partial homology
with f-50nuc protein sequence). Indeed, the resulting
cryptic epitopes in the g-50nuc protein could be, in con-
trast, accessible to an antibody response in the f-50nuc
Ali et al. Malaria Journal 2012, 11:439 Page 12 of 14
http://www.malariajournal.com/content/11/1/439protein and, therefore, induce a “species”-specific sero-
logical response.
Conclusion
Understanding the complexity of the Anopheles species
behavior is of major importance in vector control inter-
ventions to protect human populations against malaria.
Anopheles gambiae s.l. and An. funestus share particularly
anthropophilic tendencies that contribute to their vector-
ial capacity [56]. However, the existence of ecological and
behavioral differences between these species have import-
ant epidemiological consequences [57]. Indeed, during the
dry season, the densities of An. gambiae s.l. declined in
some Sub-Saharan Africa areas, whereas the An. funestus
abundance remained maximal, extending the period of
malaria transmission. Therefore, the determination of
human exposure to malaria vectors at the quantitative
level (e.g., mosquito bite densities) and at the qualitative
level (e.g., which mosquito species bite humans) should
help to adapt malaria control strategies according to the
spatial and temporal density of mosquito fauna [58].
To this end, the analysis of the human antibody re-
sponse against mosquito salivary antigens has proved to
be a relevant tool to assess host/vector contact [16,17,59].
As some areas can exhibit a high biodiversity in terms of
mosquito species, a high level of specificity is necessary to
assess individual exposure by immunological tests based
on mosquito saliva. In addition, the presence of a diverse
degree of salivary antigen cross-reactivity between differ-
ent vector species demonstrates the need to precisely de-
fine antigenic candidate biomarkers to reflect exposure to
several Anopheles species and to distinguish vector expos-
ure at the species level [9].
Therefore, the production of specific mosquito saliva
antigens in a recombinant form or by using synthetic
peptides is a promising alternative strategy for producing
safe and highly standardized antigens on a large scale
[21,24]. A gain of specificity could be achieved by the
use of synthetic peptides that do not share sequence
homology with other hematophagous arthropod species
[40]. However, the production of whole recombinant
antigenic proteins could be more efficient to detect mos-
quito exposure [25].
The well-conservedSG6 protein family within the
Anopheles Cellia subgenus made the SG6 proteins the
first anopheline salivary candidates tested for the explor-
ation of the relationship between levels of anti-gSG6 IgG
responses and individual exposure to Anopheles bites.
Encouraging data has accumulated for the use of the
gSG6 salivary protein as serological marker of exposure
to the Anopheles genus. Incontestably, the gSG6 protein
can be used to detect exposure to Anopheles bites, even
in areas of low exposure [23]. In the present study, the
IgG response against SG6 from An. gambiae and An.funestus could distinguish individuals un-exposed to
Anopheles bites from individuals exposed to Anopheles
bites and could also distinguish high levels of exposures,
independent of the anopheline Cellia species fauna.
However, gSG6 was found to elicit a higher level of re-
sponse than fSG6 orthologs. Overall, the analysis of IgG
responses against SG6 ortholog proteins sustains the use
of SG6 proteins as consistent indicators of exposure to
three major malaria vectors in tropical Africa (i.e., An.
gamgiae, An. arabiensis and An. funestus).
In contrast, the presence of significantly different patterns
and intensities of IgG responses against 50nucleotidase
anopheline orthologs supports the idea that each of these
proteins should possess specific antigenic epitopes. More-
over, the IgG response level against the f-50nuc protein
seems to be associated with An. funestus densities. These
initial tests provided encouraging preliminary information
on the immunogenicity of the anopheline 50nuc proteins
and present the promising possibility of using the
50nucleotidase salivary protein from An. funestus as the first
species-specific antigenic marker of exposure. Complemen-
tary studies are needed to confirm the present assumption.Additional files
Additional file 1: Paired-wise alignment of 50-nucleotidase proteins
from An. gambiae and An.funestus.
Additional file 2: Comparison of sequence alignment of Culicidae
protein members from the 50 nucleotidase/Apyrase family to
50-nucleotidase proteins from An. gambiae (gi|4582528).
Additional file 3: Phylogram tree constructed from the alignment
of the SG6 protein sequences from Anopheles species.
Additional file 4: Statistical analysis of variations in IgG responses
per site against the anopheline salivary proteins.Abbreviations
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